Sanford Burnham Prebys is uncovering the origins of disease
to maximize their impact on human health
needed to solve medicine's most challenging problems
meaningful clinical benefit and growing further discovery
The Latest News
-
Education
Scripting their own futures
At Sanford Burnham Prebys Graduate School of Biomedical Sciences, students embrace computational methods to enhance their research careers -
Aspiring biomedical researchers and health care professionals spent up to six weeks at Sanford Burnham Prebys participating in meaningful experiments and learning about career opportunities
-
Cancer
Coding clinic
Rapidly evolving computational tools may unlock vast archives of untapped clinical information—and help solve complex challenges confronting healthcare providers -
Genetic Disorders and Aging
Controlling thickness in fruit fly hearts reveals new pathway for heart disease
A new study in Cell Reports details how a protein previously associated with regulating metabolism in the liver also plays a part in maintaining a healthy heart by ensuring that the heart wall is neither too thick nor too thin. -
Community
Science in Pictures
A weekly image series featuring selected pictures in science • Mouse retina -
Scientists and clinicians from three local research institutions converged July 31 to discuss new ways to treat multiple addictions at Sanford Burnham Prebys open house
-
Genetic Disorders and Aging
Objective omics
Although the hypothesis is a core concept in science, unbiased omics methods may reduce attachments to incorrect hypotheses that can reduce impartiality and slow progress -
Roughly one-third of Americans do not have a primary care physician. It’s a shrinking cohort as more and more medical school students opt to become specialists. In his latest essay in the San Diego Union-Tribune, David Brenner explains why this long-term trend (with no sign of abatement) is bad news for doctors, patients and health care in general. He also proposes remedies.
-
Artificial intelligence (AI) and other computational techniques are aiding scientists and physicians in their quest to create treatments for individuals rather than populations
-
Community
8 Over 80
Congratulations to Malin Burnham and Stephen P. Cushman for being named to the San Diego Business Journal’s “8 Over 80,” recognizing their enduring achievements and contributions in business, activism and philanthropy throughout San Diego. -
Ze’ev Ronai, PhD, is stepping down as director of the National Cancer Institute-designated cancer center at Sanford Burnham Prebys, effective August 1. Cosimo Commisso, PhD, deputy director of the cancer center, will serve as interim head while a national search is conducted for a new cancer center director.
-
Community
Science in Pictures
Researchers doing behavioral experiments with honeybees sometimes use paint or e
Living History
NCI-Designated Cancer Center
Earning the NCI designation in 1981 — just five years after its modest start in downtown La Jolla — our Cancer Center truly is "the miracle on Torrey Pines Mesa."

Years in the Making
Yasuyuki Kihara wins a dream award
Research Assistant Professor Yasuyuki Kihara, Ph.D., has won an Eicosanoid Research Foundation (ERF) Young Investigator Award, an award for researchers working in lipid biology.

Living History
Along the road to discovery
It was in 1979 when Eva Engvall asked Erkki Ruoslahti a question that would change their lives forever: "Wouldn't it be great to work in San Diego?"

Next Generation
Graduate student Katja Birker's research doesn't miss a beat
"There is no magic wand to cure congenital heart conditions–we have to do the research."

Calendar
Seminar
UT Southwestern Medical Center
Seminar
Morgridge Institute for Research
Seminar
Harvard Medical School
Seminar
Dana Farber Cancer Institute
Seminar
Stanford University
Seminar
Mount Sinai School of Medicine
Seminar
NYU Langone Cancer Center
Our Partners in Discovery
We can't do it alone
Our annual Rare Disease Day symposium strengthens the global network of families, physicians and researchers to better understand and fight rare diseases in children.

Our Partners in Discovery
Getting to the finish line faster
Thanks to the philanthropic vision of Stuart and Karen Tanz, a unique collaboration seeks new treatments for diseases such as Alzheimer’s, dementia and Parkinson’s.

Our Partners in Discovery
New hope for autoimmune disease
Our partnership with Lilly—centered around a high degree of interaction—has already produced an immune therapy now in clinical trial.

Our Partners in Discovery
A master class in collaboration
Meet T. Denny Sanford, Conrad Prebys and Malin Burnham: three people who know we're stronger when we work together.

